Advertisement

Monitoring the Allotransplant Recipient

  • H. Kreis
  • J. Crosnier
Part of the Ettore Majorana International Science Series book series (EMISS, volume 9)

Abstract

Since the first long term successful transplantation in the human in 1959, our group at the Necker Hospital has been concerned that a range of immunological tests, inspired by basic research into graft immunity, be introduced into clinical transplantation. We were thus the first in 1959 to concentrate our efforts on the immunologic selection of the donor and on discovering the means of assessing the degree of immunologic similarity between donor and recipient.

Keywords

Acute Rejection Graft Survival Renal Allograft Graft Survival Rate Antibody Dependent Cell Mediate Cytotoxicity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Albrechtsen, D., Arnesen, E., Solheim, B.C. and Thorsby, E.: Significance of HLA-DR matching of B cell cross-match tests in vitro and in cadaver renal transplantation. Transplant. Proc. 9: 743, (1979).Google Scholar
  2. 2.
    Bach, J.F., Dardenne, M. and Fournier, C.: In vitro evaluation of immunosuppressive drugs. Nature. 222: 998, (1969).ADSCrossRefGoogle Scholar
  3. 3.
    Bach, M.L., Engstrom, M.A., Bach, F.M., Etheredge, E.E. and Najariam, J.G.: Specific tolerance in human kidney allograft recipients. Cell. Immunol. 3: 161, (1972).CrossRefGoogle Scholar
  4. 4.
    Buckingham, J.M., Ritts, R.E., Woods, J.E. and Ilstrup, D.M.: An assessment of cell-mediated immunity in acute allograft rejection in man. A prospective study. Mayo Clin. Proc. 52: 101, (1977).Google Scholar
  5. 5.
    Byfield, P.E., Barth, C.L., Brodie, J.A., Cosimi, A.B., Dienst, S.G., Elberg, A.J., Elfing, G.L., Hardy, M.A., Hayashi, H., Kountz, S.L., Lamborn, K.R., Loughman, B.E., Sakai A., Satoh, P.S., Zielinski, C.M. and Wechter, W.J.: The use of circulating rosette forming cells as a guide to determination of ATG dose (Dose by rosette). Transplant. Proc. 10: 627, (1978).Google Scholar
  6. 6.
    Cerilli, J., Holliday, J.E., Dawne, B.S, Fesperman, B.A. et al.: Antivascular endothelial cell antibody — Its role in transplantation. Surgery. 81: 132, (1977).Google Scholar
  7. 7.
    Cosimi, A.B., Delmarico, F.L., Burdick, J.F. and Russel, P.S.: Individualized management of immunosuppression according to serial monitoring of immunocompetence. Transplant. Proc, 10: 647, (1978).Google Scholar
  8. 8.
    Dandavino, R., Trunet, P., Descamps, B. and Kreis, H.: Prolonged withdrawal of Azathioprine in kidney transplantation. Transplant. Proc. 10: 655,(1978).Google Scholar
  9. 9.
    Dausset, J., Hors, J., Busson, M., Festenstein, H., Oliver, R.T.D., Paris, A.M.I, and Sachs, J.A.: Serologically defined HL-A antigens and long term survival of cadaver kidney transplants. New Engl. J. Med. 18: 979, (1974).CrossRefGoogle Scholar
  10. 10.
    Dejelo, C.L. and Williams, T.C.: B. Cell cross-match in renal transplantation. Lancet. 2: 241, (1977).CrossRefGoogle Scholar
  11. 11.
    Descamps, B., Gagnon, R., Debray-Sachs, M., Barbanel, C. and Crosnier, J.: Lymphocyte dependent and complement dependent antibodies in human renal allograft recipients. Transplant. Proc. 7: 635, (1975).Google Scholar
  12. 12.
    Descamps, B., Hinglais, M. and Crosnier, J.: Renal transplantation between 33 HL-A identical siblings. Transplant. Proc. 5: 231, (1973).Google Scholar
  13. 13.
    Descamps, B. N’Guyen, A.T. and Kreis, H.: New insights into immunologic selection of human cadaver renal allograft recipients based on immune response capacity criteria. Transplant. Proc. 10: 497, (1978).Google Scholar
  14. 14.
    Dimitriu, A., Debray-Sachs, M., Descamps, B., Sultan, C. and Hamburger, J,: Tritiated thymidine incorporation in blood leukocytes of renal allograft recipients. Transplant. Proc. 3: 1577, (1971).Google Scholar
  15. 15.
    Dormont, J., Sobel, A., Galanaud, P., Crevon, M.C. and Colom- bani, J.: Leukocyte migration inhibition with spleen extracts and other antigens in patients with renal allografts. Transplant. Proc. 4: 265, (1972).Google Scholar
  16. 16.
    Dossetor, J.B. and Myburgh, J.A.: Posttransplant immunologic monitoring summation. Transplant. Proc. 10: 661, (1978).Google Scholar
  17. 17.
    Ettenger, R.B., Opelz, G., Walker, J., Terasaki, P.I., Malekzadeh, M.K., Pennisi, A.J., Uittenbogaart, C.M. and Fine, R.N.: Donor-specific preformed lymphocyte antibodies and mixed lymphocyte culture (MLC). Blocking in cadaver renal allograft recipients. Transplant. Proc. 10: 479, (1978).Google Scholar
  18. 18.
    Ettenger, R.B., Opelz, G., Walker, J., Terasaki, P.I., Uittenbogaart, C., Pennisi, A.J., Malekzadeh, M.H. and Fine, R.N.: Antibodies to donor B lymphocytes and mixed lymphocyte culture blocking in cadaveric renal transplantation. Transplantation. 25: 169, (1978).CrossRefGoogle Scholar
  19. 19.
    Ettenger, R.B., Terasaki, P.I., Opelz, G., Malekzadeh, M., Pennisi, A.J., Uittenbogaart, C. and Fine, R.: Successful renal allograft across a positive cross-match foi donor B-lymphocyte alloantigens. Lancet. 2: 56, (1976).CrossRefGoogle Scholar
  20. 20.
    Gailiunas, P., Suthanthiran, M., Person, A., Strom, T.B., Carpenter, C.B. and Garovoy, M.R.: Posttransplant immunologic monitoring of the renal allograft recipient. Transplant. Proc. 10: 609, (1978).Google Scholar
  21. 21.
    Garovoy, M.R., Suthanthiran, M., Gailiunas, P., Carpenter, C.B., Graves, M., Busch, G. and Tilney, N.L.: Anti-la antibody eluted from rejected human renal allograft. Transplant. Proc. 10: 613, (1978).Google Scholar
  22. 22.
    Hamburger, J.: Immunologic follow-up of renal allograft recipients. Transplant. Proc. 4: 669, (1972).Google Scholar
  23. 23.
    Hamburger, J., Crosnier, J., Dormont, J. and Bach, J.F.: Renal Transplantation Theory and Practice. Williams and Wilkins, Baltimore. 1972, p. 26.Google Scholar
  24. 24.
    Hamburger, J. Dimitriu, A., Bankir, L., Debray-Sachs, M. and Auvert, J.: Collection of lymph from kidneys homotransplanted in man: cell transformation in vivo. Nature. 232: 633, (1971).ADSCrossRefGoogle Scholar
  25. 25.
    Hamburger, J., Vaysse, J., Crosnier, J., Tubiana, M., Lalanne, C.M., Antoine, B., Auvert, J., Soulier, J., Dormont, J., Salomon, C., Maisonnet, M. and Amiel, J.L.: Transplantation d’un rein entre jumeaux non monozygotes après irradiation du receveur. Bon fonctionnement au quatrième mois. Presse. Med. 67: 1771, (1959).Google Scholar
  26. 26.
    Hattler, B.G. and Miller, J.: Changes in human mixed lymphocyte culture reactivity as an indicator of kidney rejection. Transplant. Proc. 4: 655, (1972).Google Scholar
  27. 27.
    Hersh, E.M., Butler, W.T., Rossen, R.D. and Morgan, R.O.: Lymphocyte activation: a rapid test to predict allograft rejection. Nature. 226: 757, (1970).ADSCrossRefGoogle Scholar
  28. 28.
    Hersh, E.M., Butler, W.T., Rossen, R.D., Morgan, R.O. and Saki, W.: In vitro studies of the human response to organ allografts: appearance and detection of circulating activation lymphocytes. J. Immunol. 107: 571, (1971).Google Scholar
  29. 29.
    Iwaki, Y., Tarasaki, P.I., Park, M.S. and Billing, R.: Enhancement of human kidney allograft by cold B lymphocyte cytotoxins. Lancet. 1: 1228, (1978).CrossRefGoogle Scholar
  30. 30.
    Iwaki, Y., Terasaki, P.I., Park, M.S., Hientz, R., Silberman, H. and Berne, T.: Dilutions and specificity analysis of pretrans- plant sera. Transplant. Proc, 11: 944, (1979).Google Scholar
  31. 31.
    Iwaki, Y., Terasaki, P.I., Weil, R., Koep, L. and Starzl, T.: Retrospective tests of B cold lymphocytotoxins and transplant survival at a single center. Transplant. Proc. 11: 941, (1979).Google Scholar
  32. 32.
    Kerman, R.H. and Geis, W.P.: T-RFC monitoring of CMI events in renal allograft recipients. Transplant. Proc. 10: 633, (1978).Google Scholar
  33. 33.
    Kerman, R.H., Ing, T.S., Hano, J.F. and Geis, W.P.: Predictive value of active T-RFC in renal allograft survival. Transplant. Proc. 10: 637, (1978).Google Scholar
  34. 34.
    Kissmeyer-Nielsen F., Olsens, S., Petersen, V.P. and Fjelborg, O.: Hyperacute rejection of kidney allografts associated with pre-existing humoral antibodies against donor cells. Lancet. 2: 662, (1966).CrossRefGoogle Scholar
  35. 35.
    Kovithavongs, T., Schlaut, J., Pazderka, V., Lao, V., Pazderka, F., Bettcher, K.B. and Dossetor, J.B.: Posttransplant immunologic monitoring with special consideration of technique and interpretation of LMC. Transplant. Proc. 10: 547, (1978).Google Scholar
  36. 36.
    Kreis, H., Noel, L.H., Chailley, J., Lacombe, M., Descamp, J.M. and Crosnier, J.: Kidney graft rejection: Has the need for steroids to be re-evaluated. Lancet. 2: 1169, (1978).CrossRefGoogle Scholar
  37. 37.
    Liburd, E.M., Pazderka, V., Kovithavongs, T. and Dossetor, J. B.: Evidence for suppressor cells and reduced CML induction by the donor in transplant patients. Transplant. Proc. 10: 557, (1978).Google Scholar
  38. 38.
    Lippman, M.E., Halterman, R.H., Leventhal, B.G., Perry, S. and Thompson, E.B.: Glucocorticoid-binding proteins in human acute lymphoblastic leukemic blast cells. J. Clin. Invest. 52: 1715, (1973).CrossRefGoogle Scholar
  39. 39.
    Lobo, P.I., Westervelt, F.B. and Rudolf, L.E.: Kidney trans- plantability across a positive cross-match. Cross match assays and distribution of B lymphocytes in donor tissues. Lancet. 1: 225, (1977).Google Scholar
  40. 40.
    McConnachie, P.R., Finch, W.T, and Birtch, A.G.: Monitoring and predicting rejection. Transplant. Proc. 10: 543, (1978).Google Scholar
  41. 41.
    Mittal, K.K., Mickey, M.R., Singal, D.P. and Terasaki, P.I.: Refinement of microdroplet lymphocyte cytotoxicity test. Transplantation. 6: 913, (1968).CrossRefGoogle Scholar
  42. 42.
    Morris, J.P.: Histocompability antigens in human organ transplantation. Surgical Clinics of North America. 58: 233, (1978).Google Scholar
  43. 43.
    Myburgh, J.A. and Smit, J.A.: B-cell antibodies and clinical kidney transplantation. Transplant. Proc. 10: 529, (1978).Google Scholar
  44. 44.
    Myburgh, J.A. and Smit, J.A.: Pre-transplant lymphocyte mediated cytotoxicity (LMC) and antibody dependent cell-mediated cytotoxicity (ADCC) in kidney transplantation. Transplant. Proc. 10: 425, (1978).Google Scholar
  45. 45.
    Oliver, R.T.D., Sachs, J.A., Festenstein, H., Pegrum, G. and Moorhead, J.F.: The influence of HL-A matching, antigenic strenght and immune responsiveness on the outcome of 349 cadaver renal grafts. Lancet. 2: 1381, (1972).CrossRefGoogle Scholar
  46. 46.
    Opelz, G., Mickey, M.R. and Terasaki, P.I.: HLA matching and cadaver kidney transplant survival in North America. Influence of center variation and presensitisation. Transplantation. 23: 490, (1977).CrossRefGoogle Scholar
  47. 47.
    Parks, M.S., Terasaki, P.I. and Bernoco, D.: Autoantibody against B lymphocytes. Lancet. 2: 465, (1977).Google Scholar
  48. 48.
    Paul, L.: Antibodies directed against donor antigens in human renal allograft, Thesis, Drukkeris, J.H., Pasmans, Gravenhage, 1979, p. 140.Google Scholar
  49. 49.
    Pedersen, N. and Morris, B.: The role of the lymphatic system in the rejection of homografts: a study of lymph from renaltransplants, J. Exp. Med. 131: 936, (1970).CrossRefGoogle Scholar
  50. 50.
    Sells, R.A., Brookes, L., Baser, P. and Whitemore, D.: Methyl- prednisolone blood levels in cadaveric renal allografts recipient. Transplant. Proc. 10: 651, (1978).Google Scholar
  51. 51.
    Soulillou, J.P., Peyrat, M.A. and Guenel, J.: Studies of the antibodies against HLA, la-like, FC and/or C3 receptors present in retransplant sera: Anti B cell antibodies not associated with accelerated graft loss. Transplant. Proc. 10: 475, (1978).Google Scholar
  52. 52.
    Stiller, C.R., Dossetor, J.B., Carpenter, C.B. and Myburgh, J.A. Immunologic monitoring of the transplant recipient. Transplant. Proc. 9: 1245, (1977).Google Scholar
  53. 53.
    Stiller, C.R. and Sinclair, N.R. Stc.: Monitoring of rejection. Transplant. Proc. 11: 343, (1979).Google Scholar
  54. 54.
    Stiller, C.R., Sinclair, N.R. Stc., Abrahams, S., McGirr, D., Singh, H., Howson, W.T. and Ulan, R.A.: Anti-donor immune responses in prediction of transplant rejection. New Engl. J. Med. 294: 978, (1976).CrossRefGoogle Scholar
  55. 55.
    Stiller, C.R., Sinclair, N.R. Stc, McGirr, D., Jevnikar, A. and Lkan, R.A.: Diagnostic and prognostic value of donor specific posttransplant immune response clinical correlates and in vitro variables. Transplant, Proc. 10: 525, (1978).Google Scholar
  56. 56.
    Stinnett, J.D., Alexander, J.W., Ogle, C.K., McClellan, M.A., Brody, D. and First, R.: Immune function of kidney transplant patients in relation to infection. Transplant. Proc. 10: 639, (1978).Google Scholar
  57. 57.
    Suciu-Foca, N., Hardy, M., Kiamar, M., Weiner, J., Susinno, E., Molinaro, A.P., Jacob, J. and Reemtsma, K.: MLC inhibitory alloantibodies and outcome of kidney allografts. Transplant. Proc. Vol. 10, 2: 493, (1978).Google Scholar
  58. 58.
    Suthanthiran, M., Gailiunas, P., ST Louis, G., Fagan, G., Carpenter, C.B. and Garovoy, M.R.: Presensitization to donor B-cell (“la”) antigens associated with early allograft failure. Transplant. Proc. 9: 1807, (1977).Google Scholar
  59. 59.
    Suthanthiran, M., Gailiunas P., Fagan, G., Strom, T.B., Carpenter, C.B. and Garovoy, M.R.: Detection of anti-donor “la” antibodies: A strong correlate of rejection. Transplant. Proc. 10: 639, (1978).Google Scholar
  60. 60.
    Terasaki, P.I., Marchioro, TKL and Starzl, T.E.: First finding of preformed cytotoxic antibodies against donor cells. In: Histocompatibility Testing, 1965, Washington, D.C.: National Academy of Sciences, 1965, p. 83.Google Scholar
  61. 61.
    Terasaki, P.I., Mickey, M.R. and Kreisler, M.: Presensitizationand kidney transplant failures. Postgrad. Med. J. 47: 89, (1971)CrossRefGoogle Scholar
  62. 62.
    Thomas, F., Lee, H.M., Wolf, J.S., Mendez-Picon, G. and Thomas, J.: Monitoring and modulation of immune activity in human transplant recipients. Surgery. 79: 408, (1976).Google Scholar
  63. 63.
    Thomas, F., Mendez-Picon, G., Thomas, J., Lee, H.M. and Lower, R.: Effective monitoring and modulation of recipient immune reactivity to prevent rejection in early posttransplant period. Transplant. Proc. 10: 537, (1978).Google Scholar
  64. 64.
    Thomas, F., Thomas, J., Mendez, G. and Lee, H.M.: Pretransplant immune monitoring of donor-recipient compatibility. Transplant. Proc. 10: 429, (1978).Google Scholar
  65. 65.
    Thomas, F., Thomas, J., Mendez, G., Lee, H.M. and Lower, R.: Individualization of recipient immunosuppression by use of in vitro monitoring parameters. Transplant. Proc. 10: 621, (1978).Google Scholar
  66. 66.
    Thomas, J., Thomas, F., Johns, C. and Lee, H.M.: Consideration in immunologic monitoring of long-term transplant recipients. Transplant. Proc. 10: 569, (1978).Google Scholar
  67. 67.
    Ting, A. and Morris, P.J.: Pre and Posttransplant B-cell antibodies in renal transplantation. Transplant. Proc. 11: 393, (1979).Google Scholar
  68. 68.
    Tursz, T., Fournier, C., Kreis, H., Crosnier, J. and Bach, J.F.: T-lymphocytes in kidney allograft recipients. Br. Med. J. 1: 799, (1976).CrossRefGoogle Scholar
  69. 69.
    Van Hoof, J.F., Shippers, H.M.A., Van Der Steen, G.J. and Van Rood, J.J.: Efficacy of HL-A matching in Eurotransplant. Lancet. 2: 1385, (1972).CrossRefGoogle Scholar
  70. 70.
    Van Hoof, J.P., Hendriks, G.F.J., Schippers, H.M.A. and Van Hoof, J.J.: Influence of possible HL-A haploidentity on renal graft survival in Eurotransplant. Lancet, 1: 1130, (1974).CrossRefGoogle Scholar
  71. 71.
    Wonigeit, K. and Pichlmayr, R.: Posttransplant monitoring of donor-specific T-cell reactivity at the precursor cell level. Transplant. Proc. 10: 563, (1978).Google Scholar

Copyright information

© Plenum Press, New York 1981

Authors and Affiliations

  • H. Kreis
    • 1
  • J. Crosnier
    • 1
  1. 1.Department of NephrologyHôpital NeckerParisFrance

Personalised recommendations